Clinical Trial Update: COMPASS Study for Metastatic Castration-resistant Prostate Cancer

View source ↗

Summary

The COMPASS trial at Duke University is currently recruiting for metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer | Status: RECRUITING